Trupanion (NASDAQ:TRUP) Releases Earnings Results, Beats Expectations By $0.09 EPS
by Teresa Graham · The Cerbat GemTrupanion (NASDAQ:TRUP – Get Free Report) posted its quarterly earnings results on Wednesday. The financial services provider reported $0.03 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.09, Briefing.com reports. The firm had revenue of $327.50 million for the quarter, compared to the consensus estimate of $321.79 million. Trupanion had a negative return on equity of 6.29% and a negative net margin of 1.57%. The company’s revenue for the quarter was up 14.6% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.10) earnings per share. Trupanion updated its Q4 2024 guidance to EPS and its FY 2024 guidance to EPS.
Trupanion Trading Up 3.5 %
Shares of NASDAQ:TRUP traded up $1.87 during midday trading on Wednesday, reaching $55.12. The company’s stock had a trading volume of 771,558 shares, compared to its average volume of 680,043. The firm has a market cap of $2.32 billion, a price-to-earnings ratio of -86.13 and a beta of 1.73. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.42. Trupanion has a 1 year low of $19.14 and a 1 year high of $55.74. The business has a 50 day moving average price of $46.54 and a 200 day moving average price of $35.74.
Analyst Ratings Changes
Several equities analysts recently issued reports on the company. Northland Securities lifted their price objective on Trupanion from $35.00 to $45.00 and gave the stock a “market perform” rating in a report on Thursday, September 19th. Stifel Nicolaus lifted their price objective on Trupanion from $30.00 to $40.00 and gave the stock a “hold” rating in a report on Monday, September 23rd. Evercore ISI raised Trupanion to a “strong-buy” rating in a report on Friday, August 9th. William Blair assumed coverage on Trupanion in a report on Friday, July 19th. They set an “outperform” rating for the company. Finally, Bank of America lifted their price objective on Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a report on Friday, September 20th. Four equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $41.83.
View Our Latest Research Report on TRUP
Insider Activity
In other news, CFO Fawwad Qureshi sold 624 shares of Trupanion stock in a transaction on Monday, August 26th. The stock was sold at an average price of $46.54, for a total value of $29,040.96. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other Trupanion news, CFO Fawwad Qureshi sold 624 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $46.54, for a total transaction of $29,040.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Margaret Tooth sold 7,500 shares of the business’s stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total value of $348,600.00. Following the sale, the chief executive officer now directly owns 99,984 shares of the company’s stock, valued at approximately $4,647,256.32. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 8,764 shares of company stock valued at $405,238 over the last quarter. Company insiders own 5.50% of the company’s stock.
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Read More
- Five stocks we like better than Trupanion
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?